🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
93.47
-4.16 (-4.26%)
Nov 20, 2026, 4:00 PM EST - Market closed

Spyre Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
82.7385.7289.42188.8934.8615.14
Short-Term Investments
989.18670.81513.67150.3820.8577.99
Cash & Short-Term Investments
1,072756.53603.09339.2855.7193.13
Cash Growth
120.47%25.44%77.76%509.00%-40.18%-36.33%
Other Receivables
8.83--0.380.82
Receivables
8.83--0.380.82
Prepaid Expenses
19.0218.255.392.256.174.95
Total Current Assets
1,100777.78608.47341.5362.2698.89
Property, Plant & Equipment
----7.259.15
Other Long-Term Assets
--0.010.331.641.88
Total Assets
1,100777.78608.48341.8671.14109.93

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
9.478.90.670.90.683.32
Accrued Expenses
30.626.7727.3129.212.8213.25
Current Portion of Leases
----0.640.85
Current Unearned Revenue
----0.522.36
Other Current Liabilities
0.0823.0126.081.88-0.37
Total Current Liabilities
40.1458.6954.0631.9814.6620.14
Long-Term Leases
----44.62
Long-Term Unearned Revenue
----2.181.22
Other Long-Term Liabilities
8.053.8636.62125.87--
Total Liabilities
48.1962.5590.68157.8420.8425.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.010.010.010.01
Additional Paid-In Capital
2,2391,6861,334763.19475.97425.77
Retained Earnings
-1,329-1,128-972.43-764.41-425.62-341.81
Comprehensive Income & Other
-5.380.870.180.3-0.05-0.02
Total Common Equity
905.11559.42361.98-0.9150.3183.94
Shareholders' Equity
1,052715.24517.8184.0250.3183.94
Total Liabilities & Equity
1,100777.78608.48341.8671.14109.93

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
----4.655.48
Net Cash (Debt)
1,072756.53603.09339.2851.0787.65
Net Cash Growth
120.47%25.44%77.76%564.39%-41.74%-37.73%
Net Cash Per Share
13.0711.8112.8249.1915.1533.33
Filing Date Shares Outstanding
94.9778.5460.2836.152.621.97
Total Common Shares Outstanding
89.9578.1960.2636.062.611.97
Working Capital
1,060719.1554.41309.5547.678.75
Book Value Per Share
10.067.156.01-0.0319.2442.52
Tangible Book Value
905.11559.42361.98-0.9150.3183.94
Tangible Book Value Per Share
10.067.156.01-0.0319.2442.52
Machinery
----2.852.82
Leasehold Improvements
----4.394.39
SEC Filings: 10-K · 10-Q